Younger age and antibody induction increase the risk for infection in pediatric renal transplantation: A NAPRTCS report

American Journal of Transplantation

Volumn 7, Issue 3, 2007, Pages 662-666

  Puliyanda, D P ^a   Stablein, D M ^b   Dharnidharka, V R ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b EMMES CORPORATION   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Bacterial infection; Kidney transplantation; Pediatrics; Viral infection

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYCLONAL ANTIBODY; PREDNISONE; RAPAMYCIN; TACROLIMUS;

AGE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFECTION RATE; INFECTION RISK; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEWBORN; PEDIATRIC SURGERY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TRANSFUSION; UNIVARIATE ANALYSIS; VIRUS INFECTION;

ANTIBODIES; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSION; INFANT; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; UNITED STATES; VIRUS DISEASES;

EID: 33847731881     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01675.x     Document Type: Article

References (13)

1. Dharnidharka VR, Stablein DM, Harmon WE. Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. Am J Transplant 2004; 4: 384-389.
2. Kutinova A, Woodward RS, Ricci JF, Brennan DC. The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States. Am J Transplant 2006; 6: 129-139.
3. U.S. Renal Data System, USRDS 2003 Annual data report: Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
4. Dharnidharka VR, Caillard S, Agodoa LY, Abbott KC. Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation 2006; 27: 1662-1667.
5. Borchers AT, Perez R, Kaysen G, Ansari AA, Gershwin ME. Role of cytomegalovirus infection in allograft rejection: A review of possible mechanisms. Transpl Immunol 1999; 7: 75-82.
6. Alexander SR, Arbus GS, Butt KM et al. The 1989 report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1990; 4: 542-553.
7. Chavers BM, Gillingham KJ, Matas AJ. Complications by age in primary pediatric renal transplant recipients. Pediatr Nephrol 1997; 11: 399-403.
8. Meier-Kriesche HU, Kaplan B. Immunosuppression in elderly renal transplant recipients: Are current regimens too aggressive? Drugs Aging 2001; 18: 751-759.
9. Meier-Kriesche HU, Ojo AO, Hanson JA, Kaplan B. Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int 2001; 59: 1539-1543.
10. Meier-Kriesche HU, Friedman G, Jacobs M, Mulgaonkar S, Vaghela M, Kaplan B. Infectious complications in geriatric renal transplant patients: Comparison of two immunosuppressive protocols. Transplantation 1999; 68: 1496-1502.
11. Ettenger RB. Antibody therapy as an induction regimen in pediatric renal transplantation. Transplant Proc 1999; 31: 2677-2678.
12. Staskewitz A, Kirste G, Tonshoff B et al. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: Results after 12 months of treatment. German Pediatric Renal Transplantation Study Group. Transplantation 2001; 71: 638-644.
13. Chavers BM, Sullivan EK, Tejani A, Harmon WE. Pre-transplant blood transfusion and renal allograft outcome: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 1997; 1: 22-28.